|
|
|
Abstract Pseudomonas aeruginosa is the ubiquitous human pathogen causing different infections. The antibiotic therapy is mainly used to deal with the infections caused by P. aeruginosa. The empiric antibiotic therapy ofen does not work due to its resistance to many antibiotics. The non-antibitocs therapies of P. aeruginosa infections are paid extensive attention and many hopeful research progresses are done. This review will focus on the new progresses on the non-antibitocs therapies (including antigen-antibody immunotherapy、phage therapy and antivirulence therapy ) of P. aeruginosa infections, in addition, the problems touse these new therapies in the clinical treatment and the possible strategies to overcome them are also discussed.
|
|
Received: 17 June 2020
Published: 01 January 2021
|
|
|
|
Corresponding Authors:
Li-Guo SHANG
|
|
|
|
|
|
